Cloxacillin
Cross-source consensus on Cloxacillin from 1 sources and 4 claims.
1 sources · 4 claims
Uses
How it works
Dosage & preparation
Other
Highlighted claims
- The trial measures both total and unbound cloxacillin concentrations at steady state on days 2 and 7. — Unbound cloxacillin plasma concentrations in relation to toxicity and renal function: protocol for a prospective, observational clinical trial in a real-world Staphylococcus aureus bacteraemia population
- Cloxacillin is considered first-line therapy for methicillin-susceptible Staphylococcus aureus bacteraemia in Sweden. — Unbound cloxacillin plasma concentrations in relation to toxicity and renal function: protocol for a prospective, observational clinical trial in a real-world Staphylococcus aureus bacteraemia population
- Treatment follows standard care and usually uses intravenous cloxacillin 2 g every 6 to 8 hours for at least 7 days. — Unbound cloxacillin plasma concentrations in relation to toxicity and renal function: protocol for a prospective, observational clinical trial in a real-world Staphylococcus aureus bacteraemia population
- Cloxacillin is highly protein bound, which can make total concentrations an unreliable proxy for active drug exposure. — Unbound cloxacillin plasma concentrations in relation to toxicity and renal function: protocol for a prospective, observational clinical trial in a real-world Staphylococcus aureus bacteraemia population